SNCA and Parkinson disease: To understand how LPS-induced microglial activation might influence α-synuclein accumulation in our Parkinson’s disease model, we assessed phosphorylated α-synuclein (pSyn S129) in various brain regions of WT and Snca+/+ rats three months after SAL or LPS injection.